I keep reading how #Omicron is setting infection records across the US. Yet since we can't get a covid test ANYWHERE, the numbers must be much higher than reported. You can't get added to the official numbers if you can't be tested.
With a half-dozen companies in the psychedelics industry already with announced plans for TBI-related research, some investors may see this R&D niche as crowded.
But with a huge treatment population and an equally huge treatment market to target (estimated to reach $182 billion by 2027), there are more than enough revenue dollars on the table for second- and third-place finishers in this derby to be well-rewarded by the market.
Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."
What do you mean that people who have recovered from the virus, got it again. How's that possible? I thought once they had anti-bodies to fight off the virus, they would be safe. Were they reinfected by others? Were they not truly recovered? Or can the virus actually come back? Perhaps a person never really gets rid of it.
These wildfires are horrible, and the economic toll is unimaginable. But I'm ashamed to say that what struck me most from your article was that the #Westworld sets were destroyed! Oh no, say it ain't so!
Latest Comments
BofA Predicts Tesla EV Market Share In US Will Collapse From 69% To Just 19% By 2024
19% of 3M by 2024 is only 570k sales int he US. You willing to bet against #Tesla only selling ~170k more vehicles in two years? $TSLA
The Omicron Cloud
I keep reading how #Omicron is setting infection records across the US. Yet since we can't get a covid test ANYWHERE, the numbers must be much higher than reported. You can't get added to the official numbers if you can't be tested.
Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
Bright future for psychedelics TBI R&D
With a half-dozen companies in the psychedelics industry already with announced plans for TBI-related research, some investors may see this R&D niche as crowded.
But with a huge treatment population and an equally huge treatment market to target (estimated to reach $182 billion by 2027), there are more than enough revenue dollars on the table for second- and third-place finishers in this derby to be well-rewarded by the market.
Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."
Still Plenty Of Unknowns Around The Virus
What do you mean that people who have recovered from the virus, got it again. How's that possible? I thought once they had anti-bodies to fight off the virus, they would be safe. Were they reinfected by others? Were they not truly recovered? Or can the virus actually come back? Perhaps a person never really gets rid of it.
Market Shakeup Suggests Small Caps, Value Stocks Back In Favor
Perhaps.
Daily Stock Pick: DeNA Co Ltd
Not too shabby.
Stocks Slump And The Dollar Slides As Market Concludes Fed Is Mistaken
God help us!
Yet Another Trillion-Dollar Unfunded Liability, California Wildfires Edition
These wildfires are horrible, and the economic toll is unimaginable. But I'm ashamed to say that what struck me most from your article was that the #Westworld sets were destroyed! Oh no, say it ain't so!
Don’t Buy Walmart
#Walmart is, and always has been, a mess.